Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto L Epstein

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Current Gene Therapy|October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapyAlberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.
Expert Opinion on Biological Therapy|August 2, 2007
HSV-1 amplicon vectors: a promising and versatile tool for gene deliveryDelphine Cuchet, Corinne Potel, Joélle Thomas, et al.
The Journal of Gene Medicine|April 27, 2005
Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo proteinDelphine Cuchet, René Ferrera, Patrick Lomonte, et al.
Gene Therapy|November 12, 2024
Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an updateMatthieu Le Hars, Charles Joussain, Teddy Jégu, et al.
The Journal of General Virology|August 16, 2005
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunityHenning Lauterbach, Christine Ried, Alberto L Epstein, et al.
Human Vaccines|May 24, 2008
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Elena Berto, et al.
Journal of Virology|September 29, 2004
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated formMarie-Claude Geoffroy, Alberto L Epstein, Estelle Toublanc, et al.
Virologie (Montrouge, France)|January 9, 2020
Les vecteurs AAV pour le transfert de gène in vivo ou comment un petit virus devient grandRachel Millet, Axel Rossi, Aurélie Ploquin, et al.
Journal of Virology|June 15, 2004
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1Patrick Lomonte, Joëlle Thomas, Pascale Texier, et al.
The Journal of General Virology|June 12, 2009
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblastsEliza Tsitoura, Joëlle Thomas, Delphine Cuchet, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Current Gene Therapy|October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapyAlberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.
Expert Opinion on Biological Therapy|August 2, 2007
HSV-1 amplicon vectors: a promising and versatile tool for gene deliveryDelphine Cuchet, Corinne Potel, Joélle Thomas, et al.
The Journal of Gene Medicine|April 27, 2005
Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo proteinDelphine Cuchet, René Ferrera, Patrick Lomonte, et al.
Gene Therapy|November 12, 2024
Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an updateMatthieu Le Hars, Charles Joussain, Teddy Jégu, et al.
The Journal of General Virology|August 16, 2005
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunityHenning Lauterbach, Christine Ried, Alberto L Epstein, et al.
Human Vaccines|May 24, 2008
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Elena Berto, et al.
Journal of Virology|September 29, 2004
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated formMarie-Claude Geoffroy, Alberto L Epstein, Estelle Toublanc, et al.
Virologie (Montrouge, France)|January 9, 2020
Les vecteurs AAV pour le transfert de gène in vivo ou comment un petit virus devient grandRachel Millet, Axel Rossi, Aurélie Ploquin, et al.
Journal of Virology|June 15, 2004
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1Patrick Lomonte, Joëlle Thomas, Pascale Texier, et al.
The Journal of General Virology|June 12, 2009
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblastsEliza Tsitoura, Joëlle Thomas, Delphine Cuchet, et al.
Pageof 6